22 min listen
Diabetes Dialogue: What Teplizumab Means for Type 1 Diabetes
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: What Teplizumab Means for Type 1 Diabetes
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ratings:
Length:
27 minutes
Released:
Nov 17, 2022
Format:
Podcast episode
Description
Hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, break down what the approval of teplizumab means for type 1 diabetes. During the episode, hosts take a deep dive into type 1 diabetes staging and hypothesize around the role of CDCES in educating primary care and other specialties to optimize the potential of teplizumab.
Released:
Nov 17, 2022
Format:
Podcast episode
Titles in the series (94)
Diabetes Research & COVID-19 by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives